CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$20.75M. The highest annual figure on record is -$19.97M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.75M | – |
| FY2024 | Dec 31, 2024 | -$29.22M | – |
| FY2023 | Dec 31, 2023 | -$19.97M | – |
| FY2022 | Dec 31, 2022 | -$21.09M | – |
| FY2021 | Dec 31, 2021 | -$26.84M | – |
| FY2020 | Dec 31, 2020 | -$25.89M | – |
See a number that looks wrong?